Targovax ASA logo

TRVX - Targovax ASA News Story

NOK8.05 0.4  4.6%

Last Trade - 3:25pm

Sector
Healthcare
Size
Micro Cap
Market Cap £49.3m
Enterprise Value £46.2m
Revenue £238k
Position in Universe 989th / 1784

BRIEF-Targovax receives a patent in the US TG02

Tue 3rd October, 2017 1:49pm
Oct 3 (Reuters) - TARGOVAX ASA  TRVX.OL  
    * REG-TARGOVAX GRANTED US PATENT FOR MUTANT-RAS NEOANTIGEN 
PLATFORM 2ND GENERATION PRODUCT TG02 
 
Source text for Eikon:  ID:nGNE67WmJ4  
Further company coverage:  TRVX.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.